1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A0492C34A6C1FB7C652580EA00301FC3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-marketer-career-path-excellence-benchmarks-nurturing-core-marketing-skills-competencies-adopting-experience-based-development-approach?opendocument
18
19opendocument
2044.222.131.239
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Human Resources » Employee Training and Development

Marketer Career Path Excellence Benchmarks: Nurturing Core Marketing Skills & Competencies and Adopting an Experience-Based Development Approach

ID: 5454


Features:

14 Info Graphics

16 Data Graphics

200+ Metrics

5 Narratives

22 Best Practices


Pages/Slides: 39


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from Marketer Career Path Excellence Benchmarks: Nurturing Core Marketing Skills & Competencies and Adopting an Experience-Based Development Approach”

STUDY OVERVIEW


The biopharmaceutical industry has witnessed drastic changes in recent years, causing major shifts in how organizations position their treatments and approach market entry. Therefore, it is critical that biopharmaceutical organizations develop effective training and development programs for their marketers to meet the dynamic business needs of the future.

Best Practices, LLC undertook benchmarking research to identify critical marketer training and development approaches at biopharmaceutical companies. In particular, this study probes key skills, competencies, training curriculum and content, common language, role rotations and must-have tools for forging high-impact marketing professionals.

Marketing, commercial, and training and development leaders can use this study to identify and promote the critical skills and experiences needed among marketing personnel to succeed and grow in key roles.

KEY TOPICS


I. Marketer Training Excellence:

  • Core skills and competencies
  • Training recipients
  • Curriculum sources
  • Program funding, management and maturity

II. Ongoing Marketer Development:
  • Experience-based approaches
  • Role rotations
  • Standard tools and common language

KEY METRICS

  • How would you rate the maturity of your current marketer training and development program?
  • How important is it to train marketers on listed competency areas?
  • How successful has your organization been in using listed sources to build an effective marketing training curriculum?
  • What criteria do you use in selecting employees for participation in ongoing (i.e., post-training) marketing development programs?
  • What marketer job levels are targeted either for initial training and ongoing development programs?
  • In creating a rotation plan, how critical is it to expose marketers to listed business streams, projects and activities to maximize development and forge future leaders?
  • How effective are the listed approaches in developing individual marketer capability and enabling career path growth? (Please rank)

SAMPLE KEY FINDINGS

  • Integrate role rotations to promote development: Role rotations are a critical means of ensuring diverse marketing experiences. Nearly half of companies manage rotations strategically: 24% of companies rotate all marketers to promote growth and development, while another 24% target high-potential marketers for rotation. Currently, 29% of companies do not use any form of role rotation.

METHODOLOGY


Best Practices, LLC engaged 22 executives, directors and managers from 18 leading biopharmaceutical companies through a benchmarking survey instrument. More than 50% of research participants serve at the level of director or above.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Medical Device; Biotech; Biopharmaceutical; Manufacturing; Consumer Products; Clinical Research; Laboratories


Companies Profiled:
Abbott; Abbvie; Alcon; Amgen; Basilea Pharmaceutica; Bayer; Boehringer Ingelheim; College of American Pathologists; GlaxoSmithKline ; Lexicon Pharmaceuticals; Lilly; Merck; Novartis; Roche; Sanofi; Seattle Genetics; Sunovion; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.